Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform

Brii Biosciences Unveils BRiSC™, an siRNA Therapeutics Discovery Platform

Proprietary BRiSC™ platform to advance the discovery and development of next-generation dual-targeting siRNA medicines Initial focus on prevalent metabolic dysfunctions where complex disease biology and overlapping comorbidities will benefit from...

menu
menu